Share on LinkedInShare on LinkedIn

ARTICLE · 03 DECEMBER 2025

Non-Binding Indicative Offers In Australian Public M&A From Private Equity

Herbert Smith Freehills Kramer LLP
Herbert Smith Freehills Kramer LLP
Contributor
Herbert Smith Freehills Kramer LLP

Herbert Smith Freehills Kramer LLP

We have one of the largest Southeast Asia international law practices, working across the region...

View firm profile
Explore more from Herbert Smith Freehills Kramer LLP

We have analysed non-binding indicative offers (NBIOs) for public companies during calendar years 2022 to 2024. In particular, we have done a deep dive on private equity NBIOs.

AustraliaCorporate/Commercial Law

We have analysed non-binding indicative offers (NBIOs) for public companies during calendar years 2022 to 2024. In particular, we have done a deep dive on private equity NBIOs.

The analysis provides insights on success rates of NBIOs and how engagement might unfold. The conclusions from the data provide valuable insights for private equity bidders.

Key Findings

1. First announced on agreed deal:

For all bidder types, the majority of NBIO approaches were not announced until binding transaction documents were agreed. Only 25% of these were private equity bidders, with other private equity NBIOs being disclosed for various reasons before an agreed deal.

2. Leak risk:

Only 12% of NBIOs were leaked, and 46% of these involved private equity bidders, dispelling suggestions that Australia is a leaky market and that private equity NBIOs are more likely to be leaked.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from